In this prospective, randomized, controlled, double-blinded study, we aimed to evaluate the effects of Dextrose Prolotherapy injections in patients with coccydynia.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with coccydynia lasting longer than 6 months,
* Those unresponsive to at least 6 months of conventional conservative treatment methods,
* Those with coccygeal tenderness on palpation,
* Patients aged between 18 and 65 years.
Exclusion Criteria:
* Patients with a history of trauma within the last 3 months or postpartum coccydynia,
* Those with lesions or infections at the injection site,
* Those with dislocation or organic bone pathology of the coccyx observed on X-ray imaging,
* Those with fecal or urinary incontinence,
* Patients with poorly controlled diabetes mellitus,
* Those with a history of malignancy,
* Patients with a bleeding tendency (acquired or hereditary) \[INR \> 2 in patients using warfarin\],
* Those with a history of myelomeningocele,
* Those diagnosed with spina bifida,
* Patients with rheumatologic disease,
* Those who have undergone coccyx injection or ganglion block within the last 3 months,
* Patients with severe comorbidities.
What they're measuring
1
Visual Analog Scale
Timeframe: Before treatment, and at the 1st, 3rd, and 6th months following treatment